$20.820
+0.283 (+1.36%)At close
SIBN Profitability and Margins
Evaluating the bottom line, SI-BONE, Inc. maintains a gross margin of 79.54%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -8.58%, while the net margin is -7.30%. These profitability ratios, combined with a Return on Equity (ROE) of -8.30%, provide a clear picture of how effectively SIBN converts its operational activities into shareholder value.
SIBN Comparative Benchmarking
In the context of the broader market, SIBN competes directly with industry leaders such as BBNX and QDEL. With a market capitalization of $881.13M, it holds a significant position in the sector. When comparing efficiency, SIBN's gross margin of 79.54% stands against BBNX's 59.04% and QDEL's 35.25%. Such benchmarking helps identify whether SI-BONE, Inc. is trading at a premium or discount relative to its financial performance.
SI-BONE Inc Financial Performance
SI-BONE reported a 15.2% increase in revenue year-over-year for Q2 2026, totaling $56.01 million, and a gross margin of 79.54%, indicating strong operational efficiency despite ongoing net losses.
Financials
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.